Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Apr;29(4):602-7.
doi: 10.1007/s11606-013-2692-x. Epub 2013 Dec 24.

Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure

Yuting Zhang  1 , Seo Hyon Baik
Affiliations
Observational Study

Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure

Yuting Zhang et al. J Gen Intern Med. 2014 Apr.

Abstract

Background: Recent and national data on adherence to heart failure drugs are limited, particularly among the disabled and some small minority groups, such as Native Americans and Hispanics.

Objective: We compare medication adherence among Medicare patients with heart failure, by disability status, race/ethnicity, and income.

Design: Observational study.

Setting: US Medicare Parts A, B, and D data, 5% random sample, 2007-2009.

Participants: 149,893 elderly Medicare beneficiaries and 21,204 disabled non-elderly beneficiaries.

Main measures: We examined 5% of Medicare fee-for-service beneficiaries with heart failure in 2007-2009. The main outcome was 1-year adherence to one of three therapeutic classes: β-blockers, diuretics, and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs). Adherence was defined as having prescriptions in possession for ≥ 75% of days.

Key results: Among aged beneficiaries, 1-year adherences to at least one heart failure drug were 63%, 57%, 53%, 50%, and 52% for Whites, Asians, Hispanics, Native Americans and Blacks, respectively; among the disabled, 1-year adherence was worse for each group: 57%, 53%, 48%, 44% and 43% respectively. The racial/ethnic difference persisted after adjustment for age, gender, income, drug coverage, location and health status. Patterns of adherence were similar among beneficiaries on all three therapeutic classes. Among beneficiaries with close-to-full drug coverage, minorities were still less likely to adhere relative to Whites, OR = 0.61 (95% CI 0.58-0.64) for Hispanics, OR = 0.59 (95% CI 0.57-0.62) for Blacks and OR = 0.57 (95% CI 0.47-0.68) for Native Americans.

Conclusion: After the implementation of Medicare Part D, adherence to heart failure drugs remains problematic, especially among disabled and minority beneficiaries, including Native Americans, Blacks, and Hispanics. Even among those with close-to-full drug coverage, racial differences remain, suggesting that policies simply relying on cost reduction cannot eliminate racial differences.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion of good adherence (MPR≥0.7), by disability, and race/ethnicity sample size by disability and race/ethnicity.
Figure 2
Figure 2
Racial/ethnic difference in adherence to heart failure medications, by income sample size, by income and race/ethnicity.
See this image and copyright information in PMC

Comment in

References

    1. Heart and Stroke Statistical Update. Dallas: American Heart Association 2006; 2006.
    1. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977–2016. doi: 10.1161/CIRCULATIONAHA.109.192064. - DOI - PubMed
    1. Wu J-R, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14(3):203–10. doi: 10.1016/j.cardfail.2007.11.005. - DOI - PMC - PubMed
    1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80 % BMJ. 2003;326(7404):1419. doi: 10.1136/bmj.326.7404.1419. - DOI - PMC - PubMed
    1. Newby LK, Allen LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203–12. doi: 10.1161/CIRCULATIONAHA.105.505636. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources